Radiolabeled Probes from Derivatives of Natural Compounds Used in Nuclear Medicine
Molecules · 08.09.2024 · 29 (17) · 4260
DOI: 10.3390/molecules29174260 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 08.09.2024. Verfasst von Giuseppe Tesse und 3 weiteren Autor:innen. Beteiligte Einrichtung: Radiopharma Division, ITEL Telecomunicazioni s.r.l., 70037 Ruvo di Puglia, BA, Italy. Hauptthemen laut MEDLINE: Radiopharmaceuticals, Biological Products, Nuclear Medicine. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry for Instruction, FAR funds (Italian Ministry for Instruction, University and Research).
Abstract (Originalsprache)
Natural compounds are important precursors for the synthesis of new drugs. The development of novel molecules that are useful for various diseases is the main goal of researchers, especially for the diagnosis and treatment of many diseases. Some pathologies need to be treated with radiopharmaceuticals, and, for this reason, radiopharmaceuticals that use the radiolabeling of natural derivates molecules are arousing more and more interest. Radiopharmaceuticals can be used for both diagnostic and therapeutic purposes depending on the radionuclide. β+- and gamma-emitting radionuclides are used for diagnostic use for PET or SPECT imaging techniques, while α- and β−-emitting radionuclides are used for in metabolic radiotherapy. Based on these assumptions, the purpose of this review is to highlight the studies carried out in the last ten years, to search for potentially useful radiopharmaceuticals for nuclear medicine that use molecules of natural origin as lead structures. In this context, the main radiolabeled compounds containing natural products as scaffolds are analyzed, in particular curcumin, stilbene, chalcone, and benzofuran. Studies on structural and chemical modifications are emphasized in order to obtain a collection of potential radiopharmaceuticals that exploit the biological properties of molecules of natural origin. The radionuclides used to label these compounds are 68Ga, 44Sc, 18F, 64Cu, 99mTc, and 125I for diagnostic imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Radiopharma Division, ITEL Telecomunicazioni s.r.l., 70037 Ruvo di Puglia, BA, Italy.
- Department of Pharmacy, Università degli Studi G. d'Annunzio, 66100 Chieti, CH, Italy.
ORCID-Profile: Barbara De Filippis, Letizia Giampietro
Förderung
- Italian Ministry for Instruction
- FAR funds (Italian Ministry for Instruction, University and Research)
Zitieren
APA
Tesse, G., Tolomeo, A., De Filippis, B., & Giampietro, L. (2024). Radiolabeled Probes from Derivatives of Natural Compounds Used in Nuclear Medicine. Molecules, 29(17), 4260. https://doi.org/10.3390/molecules29174260
Vancouver
Tesse G, Tolomeo A, De Filippis B, Giampietro L. Radiolabeled Probes from Derivatives of Natural Compounds Used in Nuclear Medicine. Molecules. 2024;29(17):4260. doi:10.3390/molecules29174260
BibTeX
@article{Tesse2024,
author = {Tesse, Giuseppe and Tolomeo, Anna and De Filippis, Barbara and Giampietro, Letizia},
title = {Radiolabeled Probes from Derivatives of Natural Compounds Used in Nuclear Medicine},
journal = {Molecules},
year = {2024},
volume = {29},
number = {17},
pages = {4260},
doi = {10.3390/molecules29174260}
}
EUVIMED